Home NDC 0074-1066 NDC 0074-1066 - Skyrizi This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0074-1066
Package NDCs from labels 0074-1066-01, 0074-1066-02
Manufacturer AbbVie Inc.
Effective date 2026-03-19
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Skyrizi - AbbVie Inc. AbbVie Inc. 2026-03-19 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0074-1066-01 Skyrizi 1.2 mL in 1 CARTRIDGE INJECTION, SOLUTION 1.2 mL 180 mg in 1.2mL 173 0074-1066-02 Skyrizi 1.2 mL in 1 CARTRIDGE INJECTION, SOLUTION 1.2 mL 180 mg in 1.2mL 173
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0074-1066 SKYRIZI (RISANKIZUMAB-RZAA) KIT SKYRIZI (RISANKIZUMAB-RZAA) INJECTION [ABBVIE INC.] 162 Unmatched 20250515_7148c8eb-b39e-e20a-6494-a6df82392858.zip